documents: FDA-2022-N-2855-0001

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2022-N-2855-0001 FDA FDA-2022-N-2855 Mylan Institutional, Inc.; Withdrawal of Approval of a New Drug Application for SULFAMYLON® (Mafenide Acetate, USP) Powder for 5% Topical Solution Notice Withdrawal 2022-11-30T05:00:00Z 2022 11 2022-11-30T05:00:00Z   2022-11-30T14:46:10Z 2022-26057 0 0 090000648550a1ec

Links from other tables